Table 2. Characteristics of patients with confirmed Fabry Disease (FD).
Case | Age | Gender | GLA activity (μmol/L wb/hr) | GLA gene | LVMI (g/m2) | LVIDd (cm) | LVIDs (cm) | FD |
---|---|---|---|---|---|---|---|---|
1 | 74 | Male | 0.55 | IVS4 + 919G > A | 222 | 5.2 | 3.3 | Yes |
2 | 59 | Male | 0.76 | IVS4 + 919G > A | 144 | 3.9 | 2.9 | Yes |
3 | 59 | Male | 0.52 | IVS4 + 919G > A | 147 | 4.1 | 2.6 | Yes |
4 | 62 | Male | 1.04 | IVS4 + 919G > A | 128 | 4.6 | 3.2 | Yes |
5 | 61 | Male | 1.15 | IVS4 + 919G > A | 208 | 4.9 | 2.9 | Yes |
GLA indicates α-galactosidase enzyme; LVMI, left ventricular mass index; LVIDd, left ventricular internal dimension at end-diastole; LVIDs, left ventricular internal dimension at end-systole; FD, Fabry Disease.